Midwest Center for Oncology Research

START Midwest Center for Oncology Research is a premier clinical research facility located in Grand Rapids, Michigan, specializing in early-phase oncology drug development. Established in 2014 as a joint venture between the START Center for Cancer Research and Cancer and Hematology Centers of Western Michigan, the site provides patients with access to innovative Phase 1 and Phase 2 clinical trials for various cancer types. The center operates a 19,000-square-foot facility equipped with advanced infusion services, exam rooms, and an on-site laboratory to support complex clinical protocols. As part of the global START network, it serves as a critical partner for pharmaceutical and biotechnology companies seeking high-quality clinical data and rapid patient enrollment for novel therapeutic candidates, including peptide-drug conjugates and targeted biologics.